Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan den Broeder

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
EULAR Rheumatology Open|June 29, 2026
Low value of routine serological screening for hepatitis B in patients with rheumatoid arthritis starting rituximab therapy in a nonendemic regionPauline M Bovens, Maike Hm Wientjes, Nathan den Broeder, et al.
Rheumatology (Oxford, England)|March 31, 2021
Effectiveness and tolerability of oral vs subcutaneous methotrexate in patients with rheumatoid arthritisJanne Heuvelmans, Nathan den Broeder, Geke A H van den Elsen, et al.
Arthritis Care & Research|November 7, 2023
Limited Diagnostic and Prognostic Value of Routine Radiographs in Newly Presenting Arthritis Suspected of Rheumatoid Arthritis: A Retrospective StudyEvy Ulijn, Nathan den Broeder, David Ten Cate, et al.
BMC Rheumatology|August 1, 2022
(Dis)agreement of polymyalgia rheumatica relapse criteria, and prediction of relapse in a retrospective cohortThomas E Bolhuis, Diane Marsman, Frank H J van den Hoogen, et al.
Inflammatory Bowel Diseases|November 1, 2022
Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative ColitisEdo H J Savelkoul, Pepijn W A Thomas, Lauranne A A P Derikx, et al.
Clinical and Experimental Rheumatology|April 4, 2020
Polymyalgia rheumatica patients with and without elevated baseline acute phase reactants: distinct subgroups of polymyalgia rheumatica?Diane E Marsman, Nathan den Broeder, Nadine Boers, et al.
Rheumatology Advances in Practice|March 21, 2022
Extra-articular findings with FDG-PET/CT in rheumatoid arthritis patients: more harm than benefitEvy Ulijn, Alfons A den Broeder, Nadine Boers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Continuation versus temporary interruption of immunomodulatory agents during infections in patients with inflammatory rheumatic diseases: a randomized controlled trialMerel A A Opdam, Nathan den Broeder, Reinout van Crevel, et al.
Rheumatology (Oxford, England)|April 2, 2016
The value of routine creatine kinase and thyroid stimulating hormone testing in patients with suspected fibromyalgia: a cross-sectional studyNienke Lesuis, Judith van Vliet, Nadine Boers, et al.
European Journal of Gastroenterology & Hepatology|September 4, 2023
Cumulative thiopurine dosing and keratinocyte skin cancer in inflammatory bowel disease: a case-control studyFenna M Jansen, Nathan den Broeder, Satish F K Lubeek, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
EULAR Rheumatology Open|June 29, 2026
Low value of routine serological screening for hepatitis B in patients with rheumatoid arthritis starting rituximab therapy in a nonendemic regionPauline M Bovens, Maike Hm Wientjes, Nathan den Broeder, et al.
Rheumatology (Oxford, England)|March 31, 2021
Effectiveness and tolerability of oral vs subcutaneous methotrexate in patients with rheumatoid arthritisJanne Heuvelmans, Nathan den Broeder, Geke A H van den Elsen, et al.
Arthritis Care & Research|November 7, 2023
Limited Diagnostic and Prognostic Value of Routine Radiographs in Newly Presenting Arthritis Suspected of Rheumatoid Arthritis: A Retrospective StudyEvy Ulijn, Nathan den Broeder, David Ten Cate, et al.
BMC Rheumatology|August 1, 2022
(Dis)agreement of polymyalgia rheumatica relapse criteria, and prediction of relapse in a retrospective cohortThomas E Bolhuis, Diane Marsman, Frank H J van den Hoogen, et al.
Inflammatory Bowel Diseases|November 1, 2022
Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative ColitisEdo H J Savelkoul, Pepijn W A Thomas, Lauranne A A P Derikx, et al.
Clinical and Experimental Rheumatology|April 4, 2020
Polymyalgia rheumatica patients with and without elevated baseline acute phase reactants: distinct subgroups of polymyalgia rheumatica?Diane E Marsman, Nathan den Broeder, Nadine Boers, et al.
Rheumatology Advances in Practice|March 21, 2022
Extra-articular findings with FDG-PET/CT in rheumatoid arthritis patients: more harm than benefitEvy Ulijn, Alfons A den Broeder, Nadine Boers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Continuation versus temporary interruption of immunomodulatory agents during infections in patients with inflammatory rheumatic diseases: a randomized controlled trialMerel A A Opdam, Nathan den Broeder, Reinout van Crevel, et al.
Rheumatology (Oxford, England)|April 2, 2016
The value of routine creatine kinase and thyroid stimulating hormone testing in patients with suspected fibromyalgia: a cross-sectional studyNienke Lesuis, Judith van Vliet, Nadine Boers, et al.
European Journal of Gastroenterology & Hepatology|September 4, 2023
Cumulative thiopurine dosing and keratinocyte skin cancer in inflammatory bowel disease: a case-control studyFenna M Jansen, Nathan den Broeder, Satish F K Lubeek, et al.
Pageof 6